Newhouse-Oisten Mindy K, Peck Kimberly M, Conway Alissa A, Frieder Jessica E
Department of Psychology, Western Michigan University, Mail Stop 5439, Kalamazoo, MI 49008 USA.
Behav Anal Pract. 2017 Apr 5;10(2):145-153. doi: 10.1007/s40617-017-0184-x. eCollection 2017 Jun.
Behavior analysts often work as part of an interdisciplinary team, and different team members may prescribe different interventions for a single client. One such intervention that is commonly encountered is a change in medication. Changes in medication regimens have the potential to alter behavior in a number of ways. As such, it is important for all team members to be aware of every intervention and to consider how different interventions may interact with each other. These facts make regular and clear communication among team members vital for treatment success. While working as part of an interdisciplinary team, behavior analysts must abide by their ethics code, which sometimes means advocating for their client with the rest of the team. This article will review some possible implications of medicinal interventions, potential ethical issues that can arise, and a case study from the authors' experience. Finally, the authors propose a decision-making tree that can aid in determining the best course of action when a team member proposes an intervention in addition to, or concurrent with, interventions proposed by the behavior analyst.
行为分析师通常作为跨学科团队的一员开展工作，不同的团队成员可能会为同一个客户制定不同的干预措施。一种常见的干预措施就是药物调整。药物治疗方案的改变有可能从多个方面改变行为。因此，所有团队成员都必须了解每一项干预措施，并考虑不同干预措施之间可能产生的相互作用，这一点很重要。这些情况使得团队成员之间定期、清晰的沟通对于治疗成功至关重要。作为跨学科团队的一员，行为分析师必须遵守他们的道德准则，这有时意味着要与团队其他成员一起为客户争取权益。本文将回顾药物干预的一些可能影响、可能出现的潜在伦理问题，以及作者经验中的一个案例研究。最后，作者提出了一个决策树，当团队成员除行为分析师提出的干预措施之外，或与之同时提出一项干预措施时，该决策树有助于确定最佳行动方案。
